This Invention is directed, in part, to Amorphous and Crystalline Solid forms of (2S, 3R, 4R, 5S, 6R) - 2 - (4 - chlorine - 3 - (4 - etoxibencil) phenyl) - 6 - (methylthio) - tetrahydro 2H - piran - 3,4,5 - triol anhydrous, which is an inhibitor The Sodium Glucose Co Transporter Type 2, and may be useful in the treatment of Diabet Is and a variety of other diseases and conditions.This Invention is also directed to dosage forms comprising Solid forms of (2S, 3R, 4R, 5S, 6R) - 2 - (4 - chlorine - 3 - (4 - etoxibencil) phenyl) - 6 - (methylthio) - tetrahydro 2H - piran - 3,4,5 - triol, anhydrous, and with methods for their a modality of use. The Invention encompasses Pharmaceutical compositions Solid forms comprising described here.Another approach is to inhibit the activity sglt2 methods, as well as methods to treat, prevent and handle a variety of diseases and disorders, using solid forms described here.
展开▼